ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 55 filers reported holding ADICET BIO INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,435,000 | -23.8% | 310,540 | 0.0% | 0.08% | -15.4% |
| Q2 2021 | $3,195,000 | -38.3% | 310,540 | -21.6% | 0.09% | -39.7% |
| Q1 2021 | $5,178,000 | +7.1% | 395,875 | +15.1% | 0.15% | +0.7% |
| Q4 2020 | $4,833,000 | -2.1% | 344,011 | -17.1% | 0.15% | -0.7% |
| Q3 2020 | $4,937,000 | – | 415,189 | – | 0.15% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |